Next-generation vaccine platforms for COVID-19

doi:10.1038/s41563-020-0746-0

Review

. 2020 Aug;19(8):810-812.

doi: 10.1038/s41563-020-0746-0.

Next-generation vaccine platforms for COVID-19

Debby van Riel¹, Emmie de Wit²

Affiliations

¹ Department of Viroscience, Erasmus MC, Rotterdam, the Netherlands.
² Laboratory of Virology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT, USA. emmie.dewit@nih.gov.

PMID: 32704139
DOI: 10.1038/s41563-020-0746-0

Review

Next-generation vaccine platforms for COVID-19

Debby van Riel et al. Nat Mater. 2020 Aug.

. 2020 Aug;19(8):810-812.

doi: 10.1038/s41563-020-0746-0.

Authors

Debby van Riel¹, Emmie de Wit²

Affiliations

¹ Department of Viroscience, Erasmus MC, Rotterdam, the Netherlands.
² Laboratory of Virology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT, USA. emmie.dewit@nih.gov.

PMID: 32704139
DOI: 10.1038/s41563-020-0746-0

No abstract available

PubMed Disclaimer

Cited by

Global acceptance and hesitancy of COVID-19 vaccination: A narrative review.
Hassan W, Kazmi SK, Tahir MJ, Ullah I, Royan HA, Fahriani M, Nainu F, Rosa SGV. Hassan W, et al. Narra J. 2021 Dec;1(3):e57. doi: 10.52225/narra.v1i3.57. Epub 2021 Dec 1. Narra J. 2021. PMID: 38450215 Free PMC article. Review.
Recurring SARS-CoV-2 variants: an update on post-pandemic, co-infections and immune response.
Verma A, Manojkumar A, Dhasmana A, Tripathi MK, Jaggi M, Chauhan SC, Chauhan DS, Yallapu MM. Verma A, et al. Nanotheranostics. 2024 Feb 25;8(2):247-269. doi: 10.7150/ntno.91910. eCollection 2024. Nanotheranostics. 2024. PMID: 38444741 Free PMC article. Review.
The evolution of vaccine hesitancy through the COVID-19 pandemic: A semi-structured interview study on booster and bivalent doses.
Parsons Leigh J, FitzGerald EA, Moss SJ, Cherak MS, Brundin-Mather R, Dodds A, Stelfox HT, Dubé È, Fiest KM, Halperin DM, Ahmed SB, MacDonald SE, Straus SE, Manca T, Ng Kamstra J, Soo A, Longmore S, Kupsch S, Sept B, Halperin SA. Parsons Leigh J, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2316417. doi: 10.1080/21645515.2024.2316417. Epub 2024 Feb 23. Hum Vaccin Immunother. 2024. PMID: 38390696 Free PMC article.
Probing delivery of a lipid nanoparticle encapsulated self-amplifying mRNA vaccine using coherent Raman microscopy and multiphoton imaging.
Bera K, Rojas-Gómez RA, Mukherjee P, Snyder CE, Aksamitiene E, Alex A, Spillman DR Jr, Marjanovic M, Shabana A, Johnson R, Hood SR, Boppart SA. Bera K, et al. Sci Rep. 2024 Feb 22;14(1):4348. doi: 10.1038/s41598-024-54697-3. Sci Rep. 2024. PMID: 38388635 Free PMC article.
COVID-19 vaccine-hesitancy is associated with lower cortical volume in elderly individuals.
Nabizadeh F; Alzheimer’s disease Neuroimaging Initiative (ADNI). Nabizadeh F, et al. Neurol Lett. 2023 Apr;2(1):35-41. doi: 10.52547/nl.2.1.35. Epub 2022 Apr 15. Neurol Lett. 2023. PMID: 38327486 Free PMC article.

See all "Cited by" articles

References

1. Chan, P. K. S. Clin. Infect. Dis. 34, S58–S64 (2002). - DOI
1. Iskander, J., Strikas, R. A., Gensheimer, K. F., Cox, N. J. & Redd, S. C. Emerg. Infect. Dis. 19, 879–885 (2013). - DOI
1. Cumulative Number of Confirmed Human Cases for Avian Influenza A(H5N1) Reported to WHO, 2003–2020 (WHO, 2020); https://www.who.int/influenza/human_animal_interface/2020_MAY_tableH5N1....
1. Summary of Probable SARS Cases with Onset of Illness from 1 November 2002 to 31 July 2003 (WHO, 2003); https://www.who.int/csr/sars/country/table2004_04_21/en/
1. Wong, J. Y. et al. Epidemiology 24, 830–841 (2013). - DOI

Publication types

Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

Grants and funding

91718308/Nederlandse Organisatie voor Wetenschappelijk Onderzoek (Netherlands Organisation for Scientific Research)/International

LinkOut - more resources

Full Text Sources
- Nature Publishing Group
Other Literature Sources
- The Lens - Patent Citations

[1] Chan, P. K. S. Clin. Infect. Dis. 34, S58–S64 (2002). - DOI

[2] Chan, P. K. S. Clin. Infect. Dis. 34, S58–S64 (2002). - DOI

[3] Iskander, J., Strikas, R. A., Gensheimer, K. F., Cox, N. J. & Redd, S. C. Emerg. Infect. Dis. 19, 879–885 (2013). - DOI

[4] Iskander, J., Strikas, R. A., Gensheimer, K. F., Cox, N. J. & Redd, S. C. Emerg. Infect. Dis. 19, 879–885 (2013). - DOI

[5] Cumulative Number of Confirmed Human Cases for Avian Influenza A(H5N1) Reported to WHO, 2003–2020 (WHO, 2020); https://www.who.int/influenza/human_animal_interface/2020_MAY_tableH5N1....

[6] Cumulative Number of Confirmed Human Cases for Avian Influenza A(H5N1) Reported to WHO, 2003–2020 (WHO, 2020); https://www.who.int/influenza/human_animal_interface/2020_MAY_tableH5N1....

[7] Summary of Probable SARS Cases with Onset of Illness from 1 November 2002 to 31 July 2003 (WHO, 2003); https://www.who.int/csr/sars/country/table2004_04_21/en/

[8] Summary of Probable SARS Cases with Onset of Illness from 1 November 2002 to 31 July 2003 (WHO, 2003); https://www.who.int/csr/sars/country/table2004_04_21/en/

[9] Wong, J. Y. et al. Epidemiology 24, 830–841 (2013). - DOI

[10] Wong, J. Y. et al. Epidemiology 24, 830–841 (2013). - DOI

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Next-generation vaccine platforms for COVID-19

Affiliations

Next-generation vaccine platforms for COVID-19

Authors

Affiliations

Similar articles

Cited by

References

Publication types

MeSH terms

Substances

Grants and funding

LinkOut - more resources

Full Text Sources

Other Literature Sources